- Home
- EPSM vs OSRH Comparison
EPSM vs OSRH Comparison
Compare EPSM & OSRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | EPSM | OSRH |
|---|---|---|
| Founded | 2010 | N/A |
| Country | China | United States |
| Employees | 13 | 22 |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.7M | 17.9M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | EPSM | OSRH |
|---|---|---|
| Price | $1.34 | $0.33 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 2.3M | 885.9K |
| Earning Date | 04-29-2026 | 05-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $9.30 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.83 | $0.32 |
| 52 Week High | $155.00 | $1.57 |
Technical Indicators
Market Signals| Indicator | EPSM | OSRH |
|---|---|---|
| Relative Strength Index (RSI) | 46.68 | 30.47 |
| Support Level | $1.24 | N/A |
| Resistance Level | $1.56 | $0.45 |
| Average True Range (ATR) | 0.48 | 0.03 |
| MACD | -0.04 | -0.00 |
| Stochastic Oscillator | 13.46 | 5.38 |
Price Performance
Historical ComparisonAbout EPSM Epsium Enterprise Limited Ordinary Shares
Epsium Enterprise Ltd is a holding company and conducts business through its subsidiaries. It is engaged in import trading and wholesale selling of beverages in Macau. The company imports and sells a range of beverages, alcoholic beverages, and a small quantity of tea and fruit juice. The alcoholic beverages it sells include Chinese liquor, French cognac, Scottish whiskey, fine wine, Champagne, and other miscellaneous beverage alcohol.
About OSRH OSR Holdings Inc.
OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea. The company's pipeline products include: Vaximm, Darnatein, Woori IO, and RMC.